Erwinia tasmaniensis levansucrase shows enantiomer selection for (S)-1,2,4-butanetriol

Enhanced production of turanose using a mutant amylosucrase from Bifidobacterium thermophilum immobilized on silica carriers

Turanose (α-d-glucopyranosyl-(1→3)-α-d-fructose) is a rare disaccharide that is a potential low-calorigenic sweetener. This novel sucrose isomer has been efficiently synthesized by the amylosucrase from Bifidobacterium thermophilum (BtAS). In this study, we aimed to enhance turanose biosynthesis by designing a BtAS variant (BtAS-G374S) with improved thermal stability. The BtAS variant was immobilized on porosity-controlled silica carrier, and its enzymatic properties were thoroughly investigated. Using response surface methodology with central composite design, optimal immobilization conditions were determined to significantly boost the biosynthetic efficiency. The BtAS-G374S showed 1.6-fold higher specific activity (2.2 U/mg) than the wild-type enzyme (1.4 U/mg). Additionally, the turanose production yield of BtAS-G374S was significantly enhanced, reaching 65 %, compared to 25 % for the wild-type enzyme when reacting with 2 M sucrose. Immobilization of BtAS-G374S was optimized on controlled porosity carrier (CPC) silica carrier using Response Surface Methodology, achieving an enzyme activity of 7.89 U and an immobilization efficiency of 68.98 % under optimal conditions. Immobilization of BtAS-G374S on CPC silica carriers enhanced its pH and thermal stability. The immobilized enzyme showed a half-life of 50.23 h at 55 °C and retained 68 % of its initial biosynthetic yield after 10 reuses. These properties suggest its potential for efficient industrial turanose production.

Enhancing levan biosynthesis by destroying the strongly acidic environment caused by membrane-bound glucose dehydrogenase (mGDH) in Gluconobacter sp. MP2116

Levan produced by Gluconobacter spp. has great potential in biotechnological applications. However, Gluconobacter spp. can synthesize organic acids during fermentation, resulting in environmental acidification. Few studies have focused on the effects of environmental acidification on levan synthesis. This study revealed that the organic acids, mainly gluconic acid (GA) and 2-keto-gluconic acid (2KGA) secreted by Gluconobacter sp. MP2116 created a highly acidic environment (pH < 3) that inhibited levan biosynthesis. The levansucrase derived from strain MP2116 had high enzyme activity at pH 4.0 ∼ pH 6.5. When the ambient pH was less than 3, the enzyme activity decreased by 67 %. Knocking out the mgdh gene of membrane-bound glucose dehydrogenase (mGDH) in the GA and 2KGA synthesis pathway in strain MP2116 eliminated the inhibitory effect of high acid levels on levansucrase function. As a result, the levan yield increased from 7.4 g/l (wild-type) to 18.8 g/l (Δmgdh) during fermentation without pH control. This study provides a new strategy for improving levan production by preventing the inhibition of polysaccharide synthesis by environmental acidification.

Progress in research on the biosynthesis of 1,2,4-butanetriol by engineered microbes

1,2,4-butanetriol (BT) is a polyol with unique chemical properties, which has a stereocenter and can be divided into D-BT (the S-enantiomer) and L-BT (the R-enantiomer). BT can be used for the synthesis of 1,2,4-butanetriol trinitrate, 3-hydroxytetrahydrofuran, polyurethane, and other chemicals. It is widely used in the military industry, medicine, tobacco, polymer. At present, the BT is mainly synthesized by chemical methods, which are accompanied by harsh reaction conditions, poor selectivity, many by-products, and environmental pollution. Therefore, BT biosynthesis methods with the advantages of mild reaction conditions and green sustainability have become a current research hotspot. In this paper, the research status of microbial synthesis of BT was summarized from the following three aspects: (1) the biosynthetic pathway establishment for BT from xylose; (2) metabolic engineering strategies employed for improving BT production from xylose; (3) other substrates for BT production. Finally, the challenges and prospects of biosynthetic BT were discussed for future methods to improve competitiveness for industrial production.